US Stock MarketDetailed Quotes
CDT Conduit Pharmaceuticals
- 2.970
- 0.0000.00%
Trading May 17 16:00 ET
219.27MMarket Cap-36219P/E (TTM)
0.000High0.000Low29Volume2.910Open2.970Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)73.83MShares25.00052wk High-70.71P/B53.94MFloat Cap0.95052wk Low--Dividend TTM18.16MShs Float25.000Historical High--Div YieldTTM0.00%Amplitude0.950Historical Low0.000Avg Price1Lot Size
Conduit Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||
| Cash flow from continuing operating activities | -19.71%-2.36M | -240.91%-7.73M | -445.80%-4.8M | -149.87%-1.97M | -5.35%-2.27M | -880K | -788K | -2.15M |
| Net income from continuing operations | -112.44%-3.55M | 89.05%-535K | 157.93%1.78M | -444.63%-1.67M | -33.63%-4.89M | ---3.07M | ---307K | ---3.66M |
| Operating gains losses | 459.56%489K | -493.63%-5.63M | -339.21%-2.98M | -950.00%-136K | 859.06%1.43M | --1.25M | --16K | --149K |
| Other non cash items | 67.61%476K | 274.34%992K | 268.38%431K | --284K | --265K | --117K | ---- | ---- |
| Change In working capital | 70.83%-201K | -522.15%-2.52M | -950.60%-4.22M | -38.63%-689K | -56.08%596K | --496K | ---497K | --1.36M |
| -Change in prepaid assets | 68.97%-153K | ---990K | ---1.08M | ---493K | --0 | --0 | ---- | ---- |
| -Change in payables and accrued expense | 75.51%-48K | -354.74%-1.53M | -733.27%-3.14M | 60.56%-196K | -55.71%601K | --496K | ---497K | --1.36M |
| -Change in other current assets | ---- | 200.00%5K | --5K | ---- | ---5K | --0 | ---- | --0 |
| Cash from discontinued investing activities | ||||||||
| Operating cash flow | -19.64%-2.36M | -240.91%-7.73M | -445.80%-4.8M | -150.00%-1.97M | -5.35%-2.27M | ---880K | ---788K | ---2.15M |
| Investing cash flow | ||||||||
| Cash flow from continuing investing activities | 0 | 496.17%725K | 1,020.37%497K | -243K | -183K | -54K | 0 | 0 |
| Net investment purchase and sale | ---- | 235.81%497K | ---- | ---- | --148K | ---- | ---- | --0 |
| Net other investing changes | ---- | 168.88%228K | --0 | ---243K | ---331K | ---202K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||
| Investing cash flow | --0 | 496.17%725K | 1,020.37%497K | ---243K | ---183K | ---54K | --0 | --0 |
| Financing cash flow | ||||||||
| Cash flow from continuing financing activities | 0 | 346.45%10.93M | -144.37%-414K | 181.37%2.22M | 28.98%2.45M | 933K | 789K | 1.9M |
| Net issuance payments of debt | --0 | 106.50%2.29M | -2,111.61%-8.49M | --2.22M | 60.90%1.11M | --422K | --0 | --688K |
| Net common stock issuance | ---- | --0 | --0 | ---- | 10.83%1.34M | --511K | --789K | --1.21M |
| Net other financing activities | ---- | --8.64M | --8.49M | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||
| Financing cash flow | --0 | 346.45%10.93M | -144.37%-414K | 181.37%2.22M | 28.98%2.45M | --933K | --789K | --1.9M |
| Net cash flow | ||||||||
| Beginning cash position | --4.23M | --0 | --8.64M | --0 | --0 | --0 | --0 | --252K |
| Current changes in cash | -33,771.43%-2.36M | 393,000.00%3.93M | ---4.72M | 600.00%7K | 99.60%-1K | ---- | --1K | ---253K |
| Effect of exchange rate changes | -2,800.00%-27K | 29,800.00%299K | 30,300.00%304K | 0.00%1K | 0.00%1K | --1K | --1K | --1K |
| End cash Position | 22,950.00%1.84M | --4.23M | --4.23M | 300.00%8K | --0 | --0 | --2K | --0 |
| Free cash flow | -19.64%-2.36M | -240.91%-7.73M | -445.80%-4.8M | -150.00%-1.97M | -5.35%-2.27M | ---880K | ---788K | ---2.15M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg